(Received 26 February 1974; accepted 4 April 1974)
Published Online: 1974
| ||Format||Pages||Price|| |
|PDF (672K)||11||$25||  ADD TO CART|
Cite this document
The identification of the manufacturing source or common source of drug tablets and capsules in illicit channels provides intelligence on the diversion of commercially made products. It also provides information on the source and distribution pattern of counterfeit and other illicitly made products. Identification is made by comparison of the punch marks and formulation of unknown samples with those of authentic samples from known manufacturers [1,2]. This technique, in the Drug Enforcement Administration (DEA), has come to be known as the “ballistics” method of drug identification.
Forensic chemist, Special Testing and Research Laboratory, Drug Enforcement Administration, McLean, Va.
Chief, Office of Research and Technology, Drug Enforcement Administration, Washington, D.C.
Stock #: JFS10479J